Posted : October 25, 2011
First single-shot intradermal vaccine against M hyo
MSD Animal Health has received marketing authorisation in the EU for Porcilis M Hyo ID Once, which it claims is the first single-shot vaccine for intradermal administration against Mycoplasma hyopneumoniae (M hyo) infection in pigs.
MSD Animal Health has received marketing authorisation in the EU for Porcilis M Hyo ID Once, which it claims is the first single-shot vaccine for intradermal administration against Mycoplasma hyopneumoniae (M hyo) infection in pigs.
The product is approved in the 25 member states of the EU, plus Iceland and Norway, for the active immunisation of finishing pigs to reduce pulmonary lesions and the decrease in daily weight gain during the finishing period due to infection caused by M hyo.
MSD says the new vaccine differs from the existing Porcilis M Hyo in that it comes as a single-shot (the existing vaccine is available as a two-shot vaccine) it is approved for use as an intradermal administration (whereas the existing vaccine is approved for use as an intramuscular administration).
The firm claims the new single-shot, intradermal application of the vaccine adds flexibility and convenience in use to the current dosage scheme that has been available in Europe since 2004.
Market introduction in the individual countries will depend on the granting of national licences. That process has been scheduled for the coming four to six months.
Infection with M hyo is known to cause enzootic pneumonia, a chronic pneumonia that is said to be complicated by opportunistic bacterial infections. There is usually an incubation period of two to eight weeks before clinical signs of M hyo infection are seen.
For more information visit MSD Animal Health's website.
Last comments :
Date : 27/10/2011 from Visitor
Your comment
Follow vetsonline on
Search archives and news
COMPETITIONS
Newsletter
